8 Considerations in the Differential Diagnosis of Posttraumatic Psychosis

Slideshow

Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.

Related Videos
Erin Crown, PA-C, CAQ-Psychiatry, and John M. Kane, MD, experts on schizophrenia
brain
nicotine use
brain schizophrenia
eating disorder brain
schizophrenia
schizophrenia
exciting, brain
Related Content
Understanding the heterogeneity and complexities of the histamine monoamine system.

Histamine: Psychiatry’s Neglected Monoamine

May 17th 2024
Article
Treating ‘Morally Objectionable’ Patients

Treating ‘Morally Objectionable’ Patients

September 27th 2021
Podcast
DBS

DBS: A Solution to Treatment-Resistant Schizophrenia

May 14th 2024
Article
What Will the Future of Alzheimer Disease Treatment Look Like?

What Will the Future of Alzheimer Disease Treatment Look Like?

July 23rd 2021
Podcast
Gone in a puff of smoke? Researchers investigated the effectiveness of antipsychotics in reducing the risk of hospitalization in patients with first-episode psychosis and co-occurring CUD.

Antipsychotic Use and Psychiatric Hospitalization in First-Episode Psychosis and Cannabis Use Disorder

May 10th 2024
Article
schizophrenia

Phase 3 SOLARIS Trial Demonstrates Potential of TEV-‘749 in Schizophrenia

May 9th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.